Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Efficacy and Safety of Intensified vs Standard Prophylactic Anticoagulation Therapy in Patients Hospitalized With Coronavirus Disease 2019: Updated Systematic Review and Meta-analysis

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad506Source: DataRank Database

Efficacy and Safety of Intensified vs Standard Prophylactic Anticoagulation Therapy in Patients Hospitalized With Coronavirus Disease 2019: Updated Systematic Review and Meta-analysis is a research paper published in Open Forum Infectious Diseases (2023). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (15 grants)Impact (FWCI 0.08)OA: goldTopics (17)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Stephanie Carlin ORCID,Nicola K Wills ORCID,Sean Wasserman ORCID,Dominik Mertz ORCID,John W. Eikelboom ORCID

Live enrichment

PubMed:37953813 PMC:PMC10633781 OpenAlex:https://openalex.org/W4387500413

National Institutes of Health

Grant: K43TW011421

National Institutes of Health

Grant: U01AI170426

Daiichi-Sankyo

Ionis

Pfizer

Bayer

Leo Pharma

BMS/Pfizer

Merck

AstraZeneca and Servier

Janssen

BMS

Anthos

USV

FWCI

0.08

Citation Percentile

0.3%

Citation Trend

2024

goldLicense: cc-by

journalhttps://academic.oup.com/ofid/advance-article-pdf/doi/10.1093/ofid/ofad506/51968801/ofad506.pdf

publisherhttps://academic.oup.com/ofid/advance-article-pdf/doi/10.1093/ofid/ofad506/51968801/ofad506.pdf

publisherhttps://academic.oup.com/ofid/article-pdf/10/11/ofad506/53898737/ofad506.pdf

journalhttps://doi.org/10.1093/ofid/ofad506

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37953813

Fields of Study

COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Venous Thromboembolism Diagnosis and Management

Keywords

MedicineMeta-analysisRandomized controlled trialMEDLINERelative riskClinical trialSystematic reviewInternal medicineIntensive care medicineDiseaseCoronavirus disease 2019 (COVID-19)Emergency medicineConfidence intervalInfectious disease (medical specialty)

Sustainable Development Goals

SDG 0: Good health and well-being